A Protective Role of Glibenclamide in Inflammation-Associated Injury
Glibenclamide is the most widely used sulfonylurea drug for the treatment of type 2 diabetes mellitus (DM). Recent studies have suggested that glibenclamide reduced adverse neuroinflammation and improved behavioral outcomes following central nervous system (CNS) injury. We reviewed glibenclamide’s a...
Main Authors: | Gensheng Zhang, Xiuhui Lin, Shufang Zhang, Huiqing Xiu, Chuli Pan, Wei Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2017/3578702 |
Similar Items
-
The Role of Macrophages in the Pathogenesis of ALI/ARDS
by: Xiaofang Huang, et al.
Published: (2018-01-01) -
Glibenclamide for the Treatment of Acute CNS Injury
by: J. Marc Simard, et al.
Published: (2013-10-01) -
Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis
by: Shufang Zhang, et al.
Published: (2015-01-01) -
Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence
by: Ruchira M. Jha, et al.
Published: (2020-01-01) -
The Protective Effect of Glibenclamide in a Model of Hemorrhagic Encephalopathy of Prematurity
by: J. Marc Simard, et al.
Published: (2013-03-01)